Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Bever

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemistry|June 14, 2006
The structural basis of sirtuin substrate affinityMichael S Cosgrove, Katherine Bever, Jose L Avalos, et al.
Abdominal Radiology (New York)|June 17, 2024
Cross-sectional imaging of gastric cancer: pearls, pitfalls and lessons learned from multidisciplinary conferenceStephen Kwak, Mark Duncan, Fabian M Johnston, et al.
Cancer Research Communications|March 27, 2023
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal AdenocarcinomaEric S Christenson, Su Jin Lim, Jennifer Durham, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trialJason J Luke, Katherine Bever, F Stephen Hodi, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal CancerEric S Christenson, Valerie Lee, Hao Wang, et al.
Journal of Gastrointestinal Oncology|May 22, 2026
Assessment of colorectal cancer recurrence risk following solid organ transplantationDavid B Meyer, Angela Gifford, Taylor Bradley, et al.
Journal for Immunotherapy of Cancer|June 7, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancerRonan J Kelly, Katherine Bever, Joseph Chao, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemistry|June 14, 2006
The structural basis of sirtuin substrate affinityMichael S Cosgrove, Katherine Bever, Jose L Avalos, et al.
Abdominal Radiology (New York)|June 17, 2024
Cross-sectional imaging of gastric cancer: pearls, pitfalls and lessons learned from multidisciplinary conferenceStephen Kwak, Mark Duncan, Fabian M Johnston, et al.
Cancer Research Communications|March 27, 2023
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal AdenocarcinomaEric S Christenson, Su Jin Lim, Jennifer Durham, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trialJason J Luke, Katherine Bever, F Stephen Hodi, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal CancerEric S Christenson, Valerie Lee, Hao Wang, et al.
Journal of Gastrointestinal Oncology|May 22, 2026
Assessment of colorectal cancer recurrence risk following solid organ transplantationDavid B Meyer, Angela Gifford, Taylor Bradley, et al.
Journal for Immunotherapy of Cancer|June 7, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancerRonan J Kelly, Katherine Bever, Joseph Chao, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Pageof 1